Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Cattaneo

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Plos Pathogens|June 30, 2010
Paramyxovirus entry and targeted vectors for cancer therapyRoberto Cattaneo
Journal of Virology|April 14, 2004
Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnetRoberto Cattaneo
Journal of Virology|October 14, 2004
Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor functionPatricia Devaux, Roberto Cattaneo
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Development of Entry-Targeted Oncolytic Measles VirusesMichael D Mühlebach, Roberto Cattaneo
Nature Reviews. Microbiology|December 3, 2013
New viruses for cancer therapy: meeting clinical needsTanner S Miest, Roberto Cattaneo
Journal of Virology|April 5, 2002
Amino-terminal precursor sequence modulates canine distemper virus fusion protein functionVeronika von Messling, Roberto Cattaneo
Journal of Virology|September 13, 2003
N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusionVeronika von Messling, Roberto Cattaneo
Science (New York, N.Y.)|August 11, 2012
Virology. A henipavirus vaccine in sightVeronika von Messling, Roberto Cattaneo
Viruses|June 27, 2025
Trafficking and Activation of <i>Henipavirus</i>, <i>Parahenipavirus,</i> and Henipa-like Virus Fusion ProteinsChanakha K Navaratnarajah, Roberto Cattaneo
Plos Pathogens|March 17, 2017
How to develop viruses into anticancer weaponsRoberto Cattaneo, Stephen J Russell
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Plos Pathogens|June 30, 2010
Paramyxovirus entry and targeted vectors for cancer therapyRoberto Cattaneo
Journal of Virology|April 14, 2004
Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens' magnetRoberto Cattaneo
Journal of Virology|October 14, 2004
Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor functionPatricia Devaux, Roberto Cattaneo
Methods in Molecular Biology (Clifton, N.J.)|September 6, 2019
Development of Entry-Targeted Oncolytic Measles VirusesMichael D Mühlebach, Roberto Cattaneo
Nature Reviews. Microbiology|December 3, 2013
New viruses for cancer therapy: meeting clinical needsTanner S Miest, Roberto Cattaneo
Journal of Virology|April 5, 2002
Amino-terminal precursor sequence modulates canine distemper virus fusion protein functionVeronika von Messling, Roberto Cattaneo
Journal of Virology|September 13, 2003
N-linked glycans with similar location in the fusion protein head modulate paramyxovirus fusionVeronika von Messling, Roberto Cattaneo
Science (New York, N.Y.)|August 11, 2012
Virology. A henipavirus vaccine in sightVeronika von Messling, Roberto Cattaneo
Viruses|June 27, 2025
Trafficking and Activation of <i>Henipavirus</i>, <i>Parahenipavirus,</i> and Henipa-like Virus Fusion ProteinsChanakha K Navaratnarajah, Roberto Cattaneo
Plos Pathogens|March 17, 2017
How to develop viruses into anticancer weaponsRoberto Cattaneo, Stephen J Russell
Pageof 14